NCT02094105
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Cancer Institute/Hospital of Ci County Handan, Hebei, China
Clinical trial condition
Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
205 public trials
78 recruiting studies
Esophageal Squamous Cell Carcinoma trial results
NCT01605305
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
Not specified
Active, Not Recruiting
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
NCT04543617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
- Cancer Center of Kansas Wichita, Kansas, United States
- Great Lakes Cancer Center Williamsville, New York, United States
- Instituto de Investigaciones Metabolicas (Idim) Buenos Aires, Argentina
Active, Not Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
NCT06304974
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Active, Not Recruiting
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047
- Conditions
- Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
- Locations
-
- Institut de cancérologie de l'Ouest Angers, France
- Clinique Sainte Catherine Avignon, France
- Centre Hospitalier de la Côte Basque Bayonne, France
- CHU Bordeaux - Hôpial Saint André Bordeaux, France
Active, Not Recruiting
Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06165380
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
- Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
Active, Not Recruiting
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
NCT04929392
- Conditions
- Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +31 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
NCT04140500
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
- Locations
-
- Rigshospitalet København Ø, Denmark
- Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
- LLC Arensia Explorer Medicine Tbilisi, Georgia
- Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
Active, Not Recruiting
an AI-Driven Four-Tier Invasion Depth Classification for Early Esophageal Cancer
NCT07605663
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Zhongshan Hospital Shanghai, China
Active, Not Recruiting
Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
NCT04550260
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- Research Site Atlanta, Georgia, United States
- Research Site Louisville, Kentucky, United States
- Research Site Dallas, Texas, United States
- Research Site Fairfax, Virginia, United States